Toxicology pharmacokinetics

Overview of the non-clinical testing strategy Pharmacology Pharmacokinetics Toxicology... 

Since the introduction of nalidixic acid in 1963, structural modifications on the quinolones have been performed to improve either the antibacterial efficacy or pharmacokinetic/toxicologic profiles of these compounds. The newest quinolones possess broad-spectrum activity, favorable pharmacokinetic/toxicologic profiles, and potency against bacterial strains that are resistant to older generations of quinolones. This section describes the synthetic procedures for the new generation of quinolones that were studied during the 1995-2005 period. 

Fig. 2.1 Lead discovery requires an integrated approach to address a multiple response surface optimization problem properties related to pharmacokinetics, toxicology and pharmacodynamics require optimization for novel chemotypes. The increased difficulty of finding such optima is suggested by darker backgrounds. Modified from [4] with permission.

In view of the regulatory delay that was caused by the need to apply for a CTC, a Statutory Order (SI 1974/498) was made during 1974, to provide an exemption from the need to hold a CTC in such cases, subject to certain conditions. This order applied to trials conducted by doctors and dentists on their own responsibility (DDX). The basis of the clinical trial exemption (CTX) scheme, introduced in 1981, to include studies initiated by the pharmaceutical industry, was that together with a detailed clinical trial protocol and summaries of chemical, pharmaceutical, pharmacological, pharmacokinetic, toxicological and human volunteer studies, a clinical trial in patients may proceed without the need for the additional details normally required for a CTC or Product Licence application. This exemption scheme was based on the requirements that ... 

After assessing patterns of use in farm animals, the metabolism and pharmacokinetics, toxicological data, residue depletion (under field conditions) and analytical criteria for each compound, JECFA recommends acceptable daily intakes (ADIs) for them. 

Mass spectrometry (MS) is playing an increasingly visible role in the molecular characterization of combinatorial libraries, natural products, drug metabolism and pharmacokinetics, toxicology and forensic investigations, and proteomics. Toward this end, electrospray ionization (ESI), atmospheric pressure chemical ionization (APCI), and atmospheric pressure photo-ionization (APPI) have proven valuable for both qualitative and quantitative screening of small molecules (e.g., pharmaceutical products) [9-14]. 

The basis of the CTX scheme is that, following an evaluation of a detailed clinical trial protocol and summaries of chemical, pharmaceutical, pharmacological, pharmacokinetic, toxicological and, when appropriate, human volunteer studies, a clinical trial may be permitted. This obviates the provision of the additional details normally required for a Clinical Trial Certificate or Product Licence application. 

Non-clinical Written and Tabulated Summary Pharmacology Pharmacokinetics Toxicology Clinical Summary Biopharmaceutics and Associated Analytical Methods Clinical Pharmacology Studies Clinical Efficacy Clinical Safety... 

Development Methodologies following GLP-pharmacodynamics, pharmacokinetics, toxicology, drug delivery systems... 

Pharmaco-EEG study M. Fink, F. Irwin, Clin. Pharmacol. Ther. 30, 336 (1981). Toxicity studies C. Hewett et al, Arzneimittel-Forsch. 36, 592 (1986). Series of articles on pharmacology, pharmacokinetics, toxicology ibid. 517 620. 

University of Groningen Department Pharmacokinetics, Toxicology and Targeting Research Institute of Pharmacy Antonius Deusinglaan 1 Groningen 9713 AV The Netherlands... 

Recently, the influence of size, shape, and surface chemistry of nanoparticle systems on drug delivery performance and modalities like blood circulation time, biodistribution, pharmacokinetics, toxicology, targeting ability, and internalization have been comprehensively reviewed and outlined by Petros and DeSimone [107]. Nanoparticle uptake by, e.g., internalization in the target cells, is still treated as the key factor in this and other earlier articles. Important properties and requirements in this respect were identified and can be summarized by the following four points ... 

---